Document Detail

Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes.
MedLine Citation:
PMID:  20825469     Owner:  NLM     Status:  In-Data-Review    
Objective:  To study the frequency, demographics, clinical characteristics, and outcomes of patients with an antemortem diagnosis of fibrocartilaginous embolism (FCE), a rare cause of spinal cord and cerebral infarction because of the presumed embolization of nucleus pulposus material into the vascular circulation. Methods:  We retrospectively reviewed the institutional experience of patients who received an antemortem diagnosis of FCE by their treating physician at the Mayo Clinic (Rochester, MN, USA) from 1997 to 2009. All patients underwent laboratory, radiological, and clinical exclusion of other possible and related diagnoses. Results:  Of 164 patients with acute spinal cord infarction seen during the study timeframe, 9 (5.5%; 95% CI 2.5, 10.2%) met inclusion criteria for high likelihood of FCE (6 men, 3 women; median age 46 years old, range 21-64). All patients were severely affected (median modified Rankin Scale 4, median Barthel index 45; mean time to evaluation 57 days). One patient (1/9) experienced concomitant cerebral infarction. No patients had noticeable improvement from steroid treatment. Conclusion:  The diagnosis of FCE in life is common at this referral center, accounting for 5.5% of all cases of acute spinal cord infarction seen. Although FCE is a postmortem diagnosis, we propose clinical criteria for FCE in life to better characterize the relatively high number of patients with unexplained ischaemic myelopathy.
F J Mateen; P A Monrad; A N Leep Hunderfund; C E Robertson; E J Sorenson
Related Documents :
23929639 - The clinical manifestations and survival of systemic lupus erythematosus patients in tu...
24978919 - Optimizing outpatient phlebotomy staffing: tools to assess staffing needs and monitor e...
9148719 - Experience of clinical use of the odstock dropped foot stimulator.
23065389 - An update for community-acquired bacterial pneumonia pharmacotherapy: what's new and wh...
23072859 - Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis.
23328259 - Reduction of immunocompetent t cells followed by prolonged lymphopenia in severe sepsis...
19619699 - Rates and predictors of appropriate implantable cardioverter-defibrillator therapy deli...
7259989 - Erythropoietin measurements in the differential diagnosis of polycythaemia.
3193659 - Serum pepsinogen 1, gastrin, abo blood groups, secretor status of abh substances and be...
Publication Detail:
Type:  Journal Article     Date:  2010-09-06
Journal Detail:
Title:  European journal of neurology : the official journal of the European Federation of Neurological Societies     Volume:  18     ISSN:  1468-1331     ISO Abbreviation:  Eur. J. Neurol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9506311     Medline TA:  Eur J Neurol     Country:  England    
Other Details:
Languages:  eng     Pagination:  218-25     Citation Subset:  IM    
Copyright Information:
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.
The Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Neuromyelitis optica after Japanese encephalitis vaccination.
Next Document:  Headache, migraine and cardiovascular risk factors: The HUNT study.